Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07111390) titled 'Feasibility of Home-Based Intermittent 60Hz Light Therapy for Major Depressive Disorder (MDD)' on Aug. 1.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: NYU Langone Health
Condition:
Depression
MDD
Major Depressive Disorder
Major Depressive Episode
Intervention:
Device: 60Hz Intermittent Light Therapy
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: August 25, 2025
Target Sample Size: 40
Countries...